Research › Practitioner Perspectives
Evidence-Based QEEG Neurofeedback Therapy: Clinical Outcomes in ADHD
STS Instructor Authored by David Cantor
Share
Article at a glance
Practitioner perspective. This article describes a clinician's own experience, cases or methods. It was not peer reviewed or controlled, so it can be subjective. Read it as practical insight, not as evidence that a treatment works.
- Area
- Practitioner Perspectives
- Authors
- Cantor DS, Tuttle D
- Journal
- IPEG 17th Biennial Conference, New York (poster)
- Year
- 2012
- Participants
- 57 charts reviewed (41 never medicated, 3 came off medication, 5 stayed on)
- Population
- Children, Adolescents, Adults
- Protocol
- Individualized QEEG-guided neurofeedback; IVA continuous performance test and 19-channel QEEG before and during treatment
- Sessions
- 5 to 102 hours (average about 21)
- Equipment
- Cadwell Easy-2 (QEEG); NeuroGuide
Key findings
- Retrospective chart review of 57 patients aged 6 to 38 with an ADHD diagnosis
- All 41 never-medicated patients improved significantly on IVA attention and response-control scores
- Of 29 with QEEGs before and after, 20 (69%) showed significant QEEG improvement
- Patients on medication showed mixed results; no control group
A conference poster reviewing the charts of 57 patients aged 6 to 38 with an ADHD diagnosis, treated in one private practice with neurofeedback protocols tailored to each person's QEEG. Continuous performance test scores and QEEG z-scores were taken before treatment and every 5 to 10 hours of training. All 41 patients who were never on medication improved significantly on attention and response-control scores, and their QEEG measures improved or normalized. Patients who stayed on medication showed mixed results with no overall significant gain. The authors suggest medication may get in the way of individualized training. This is an uncontrolled retrospective review presented as a poster, not a peer-reviewed paper.